Showing results (31-40 of 68) with videos related to

Sort By:
Pageof 7
Plos One|June 22, 2023
An oncogenic CTNNB1 mutation is predictive of post-operative recurrence-free survival in an EGFR-mutant lung adenocarcinomaYeseul Kim, Bokyung Ahn, Shinkyo Yoon, et al.
Journal of Korean Medical Science|February 8, 2020
Involvement of the TNF-α Pathway in TKI Resistance and Suggestion of TNFR1 as a Predictive Biomarker for TKI Responsiveness in Clear Cell Renal Cell CarcinomaHee Sang Hwang, Yun Yong Park, Su Jin Shin, et al.
Medicine|January 14, 2022
Long-term outcomes of large artery thromboangiitis obliterans and comparison with small artery thromboangiitis obliteransSang Ah Lee, Min-Jae Jeong, Gi-Young Ko, et al.
Annals of Surgical Oncology|March 18, 2014
Endoscopic and pathologic findings associated with clinical outcomes of melanoma in the upper gastrointestinal tractJi Yong Ahn, Hee Sang Hwang, Young Soo Park, et al.
The Korean Journal of Gastroenterology = Taehan Sohwagi Hakhoe Chi|June 28, 2012
Diagnosis of an accessory spleen mimicking a gastric submucosal tumor using endoscopic ultrasonography-guided fine-needle aspirationJi Yong Ahn, Hwoon-Yong Jung, Do Hoon Kim, et al.
European Radiology|April 30, 2020
Comparison between neuroendocrine carcinomas and well-differentiated neuroendocrine tumors of the pancreas using dynamic enhanced CTHyo Jung Park, Hyoung Jung Kim, Kyung Won Kim, et al.
Cancer Research and Treatment|March 3, 2022
PD-L1 Upregulation by the mTOR Pathway in VEGFR-TKI-Resistant Metastatic Clear Cell Renal Cell CarcinomaSe Un Jeong, Hee Sang Hwang, Ja-Min Park, et al.
Investigational New Drugs|December 12, 2018
Efficacy and safety of lanreotide in Korean patients with metastatic, well-differentiated gastroenteropancreatic-neuroendocrine tumors: a retrospective analysisJunho Kang, Changhoon Yoo, Hee-Sang Hwang, et al.
Respiratory Research|October 20, 2020
Long-term clinical course and outcomes of immunoglobulin G4-related lung diseaseJieun Kang, Shinhee Park, Eun Jin Chae, et al.
EJNMMI Research|June 17, 2020
Tumour-to-liver ratio determined by [68Ga]Ga-DOTA-TOC PET/CT as a prognostic factor of lanreotide efficacy for patients with well-differentiated gastroenteropancreatic-neuroendocrine tumoursYong-Il Kim, Changhoon Yoo, Seung Jun Oh, et al.
Pageof 7